ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	12 December 2020
Main ID:	NCT03165591
Date of registration:	18/05/2017
Prospective Registration:	No
Primary sponsor:	Immunitor LLC
Public title:	Open Label Immunotherapy Trial of Inoperable Pancreatic Cancer V3-P
Scientific title:	Open Label Phase II Immunotherapy Trial of Inoperable Pancreatic Cancer
Date of first enrolment:	May 1, 2017
Target sample size:	30
Recruitment status:	Recruiting
URL:	https://clinicaltrials.gov/show/NCT03165591
Study type:	Interventional
Study design:	Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Phase:	Phase 1/Phase 2

Countries of recruitment
Mongolia

Contacts

Name:	Aldar Bourinbaiar, MD
Address:
Telephone:	97695130306
Email:	aldar@immunitor.com
Affiliation:

Name:	Allen Bain, PhD
Address:
Telephone:
Email:
Affiliation:	Immunitor Inc.

Name:	aldar Bourinbaiar, MD/PhD, PhD
Address:
Telephone:	+976-95130306
Email:	immunitor@gmail.com
Affiliation:

Key inclusion & exclusion criteria

Inclusion Criteria:

- diagnosis of inoperable pancreatic cancer

- higher than normal of serum CA19.9 tumor marker levels (40 IU/ml)

- must be able to swallow tablets

Exclusion Criteria:

- negative for CA19.9

- pregnant, breast feeding women

- unwillingness to provide written consent

Age minimum: 18 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Pancreatic Cancer Non-resectable

Intervention(s)

Biological: V3-P

Primary Outcome(s)

Effect of V3-P on tumor burden [Time Frame: 3 months]

Secondary Outcome(s)

Effect of V3-P on sugar and bilirubin levels [Time Frame: 3 months]

Safety of V3-P [Time Frame: 3 months]

Secondary ID(s)

Panc-001

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.